Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Found 6146 publications
Investigation Report on Chinese Ossotide Market, 2018-2022 US$ 2,200.00

... years. TOPICS COVERED: Development environment of Ossotide Sales of Ossotide in China Competition pattern of Chinese Ossotide Market Major Ossotide manufacturers in China Prices of Ossotide in China Prospect of the Chinese Ossotide market from 2018 to 2022

Aug, 2018 30 pages
Investigation Report on Chinese Insulin Glargine Market, 2018-2022 US$ 2,200.00

... of Insulin Glargine Supply of and demand for Insulin Glargine in China Major Insulin Glargine manufacturers in China Prices of Insulin Glargine in China Factors influencing the development of the Chinese Insulin Glargine market from 2018 to 2022 Prospect of the Chinese Insulin Glargine ...

Aug, 2018 30 pages
Investigation Report on Chinese Atorvastatin Market, 2018-2022 US$ 2,200.00

... demand for Atorvastatin. TOPICS COVERED: Development environment of Atorvastatin in China Sales of Atorvastatin in China Prices of Atorvastatin in China Major Atorvastatin manufacturers in China Market share of Atorvastatin by dosage form in China Prospect of Chinese Atorvastatin Market, 2018-2022 ...

Aug, 2018 30 pages
Yellow Fever Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...

Aug, 2018 40 pages
Vancomycin Resistant Enterococcal (VRE) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

... use format. SCOPE OF VANCOMYCIN RESISTANT ENTEROCOCCAL (VRE) INFECTION PIPELINE REPORT INCLUDES Panorama of Vancomycin Resistant Enterococcal (VRE) Infection pipeline markets including statistics on therapeutic drugs and companies involved Vancomycin Resistant Enterococcal (VRE) Infection Pipeline candidates ...

Aug, 2018 70 pages
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...

Aug, 2018 35 pages
Tetanus Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...

Aug, 2018 65 pages
Rubella (German measles) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...

Aug, 2018 30 pages
Rotavirus Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...

Aug, 2018 45 pages
Rabies Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...

Aug, 2018 60 pages
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...

Aug, 2018 30 pages
Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Progressive Multifocal Leukoencephalopathy (PML) pipeline products. DISEASE OVERVIEW Progressive multifocal leukoencephalopathy (PML) is a ...

Aug, 2018 35 pages
Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningococcus (Neisseria meningitidis Infection) pipeline products. DISEASE OVERVIEW Meningococcal infection is one of the ...

Aug, 2018 65 pages
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...

Aug, 2018 90 pages
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...

Aug, 2018 90 pages
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...

Aug, 2018 40 pages
Human Parainfluenza Virus 3 (HPIV-3) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

... . SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 (HPIV-3) INFECTION PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 (HPIV-3) Infection pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 (HPIV-3) Infection Pipeline ...

Aug, 2018 30 pages
Herpes Labialis Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...

Aug, 2018 35 pages
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...

Aug, 2018 50 pages
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...

Aug, 2018 35 pages
Haemophilus influenza (Hib)- Type B Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

... disease publication with comprehensive information of Haemophilus influenza (Hib) Infection pipeline products. DISEASE OVERVIEW Haemophilus influenza bacteria (Hib) often causes various types of infections ranging from mild ...

Aug, 2018 60 pages
Diphtheria Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...

Aug, 2018 60 pages
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptosporidiosis (crypto) pipeline products. DISEASE OVERVIEW Cryptosporidium is one of the most widespread intestinal ...

Aug, 2018 30 pages
Chlamydia Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Chlamydia Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chlamydia pipeline products. DISEASE OVERVIEW Chlamydia infections are caused by Chlamydia trachomatis bacteria. Worldwide, the ...

Aug, 2018 60 pages
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chikungunya (CHIKV) Infection pipeline products. DISEASE OVERVIEW Chikungunya fever is a viral fever, caused ...

Aug, 2018 90 pages
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, also known as American Trypanosomiasis, is one of the ...

Aug, 2018 70 pages
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00

... is the main challenge in detecting and treating Burkholderia Infections disease. Individuals with low immunity levels and ... Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia ...

Aug, 2018 45 pages
Aspergillosis Drug Development Pipeline Study, H2 2018 US$ 1,200.00

Aspergillosis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Aspergillosis pipeline products. DISEASE OVERVIEW Aspergillus is a general fungus type that causes ...

Aug, 2018 90 pages
Global Vitamin Consumption Market Size Study By Product (Vitamin A, Vitamin B5, Vitamin C, Vitamin E, Vitamin B3, Vitamin D3, Others), By Application (Pharmaceuticals & Cosmetics, Feed... US$ 3,150.00 US$ 2,520.00

... categories of fat-soluble and water-soluble vitamins. The regional analysis of Global Vitamin Consumption Market is considered for the key regions such ... . Target Audience of the Vitamin Consumption Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists ...

Aug, 2018 120 pages
2018-2023 Global and Regional Insulin Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report US$ 3,500.00

... and the market size is projected from 2018 to 2023. Diabetes affected the sugar level in the ... Lilly and Company By Type Animal Insulin, Regular Human Insulin, Insulin Analogue By Application Short acting, ... in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom ...

Aug, 2018 153 pages
Global Respiratory Drug Market Research and Forecast 2018-2023 US$ 3,600.00

... : Global Respiratory drug market Research and Analysis, By Drug Global Respiratory drug market Research and Analysis, By Drug Class Global Respiratory drug market Research and Analysis, By Route of Administration Global Respiratory drug market Research and Analysis, By End User Global Respiratory drug market ...

Jul, 2018
Global Cardiovascular Drug Market Research and Forecast 2018-2023 US$ 3,600.00

... government policies impacting the Global Cardiovascular drug market. Insights about market determinants which are stimulating the Global Cardiovascular drug market. Detailed and extensive market segments with regional distribution ...

Jul, 2018
Global 3D Printed Drugs Market Research and Forecast 2018-2027 US$ 3,600.00

... government policies impacting the global 3D Printed Drugs Market Insights about market determinants which are stimulating the global 3D Printed Drugs Market Detailed and extensive market segments with regional distribution ...

Jul, 2018
Global Vitamin Premixes Industry Market Research 2018 US$ 2,600.00

... of the Vitamin Premixes market? 9. What are the Vitamin Premixes market challenges to market growth? 10. What are the Vitamin Premixes market opportunities and threats faced by the vendors in the global Vitamin Premixes market? Objective of Studies ...

Aug, 2018 151 pages
2018-2023 Global and Regional Unit Drug Dose Delivery System Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report US$ 3,500.00

... from 2018 to 2023. The increasing need for accurate dosing has boosted the growth of the unit ... from 2012 to 2017 and forecast data from 2018 to 2023. The growth factors of the market is ... explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research ...

Aug, 2018 171 pages
2018-2023 Global and Regional Drugs of Abuse Testing Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report US$ 3,500.00

... study is 2017, and the market size is projected from 2018 to 2023. The market for drugs of abuse testing, which can be an in-house or onsite examination ... of the market are explained in detail. Data and information by manufacturer, by region, by type, by application and etc, and custom research can be added ...

Aug, 2018 197 pages
Global Respiratory Drugs Pipeline Analysis Market 2018 US$ 3,500.00

Respiratory Drugs Pipeline Analysis Overview: Pulmonary medicine is the branch of medical science that deals with diagnosis, prevention, and treatment of diseases affecting the respiratory system. Respiratory drugs finds ...

Apr, 2018 188 pages
Drugs of Abuse / Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018 US$ 2,500.00

Drugs of Abuse/Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018 SUMMARY GlobalData's Medical Devices sector report, “Drugs of Abuse/Toxicology Rapid Tests - Medical Devices Pipeline Assessment, 2018' provides an overview of Drugs of Abuse/Toxicology Rapid Tests currently in pipeline stage. ...

Jul, 2018 43 pages
Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast... US$ 3,150.00 US$ 2,520.00

Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025. Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150 ... the major players. Target Audience of the Global Pharmacovigilance and Drug Safety Software Market In Market Study: Key Consulting ...

Jul, 2018 120 pages
Cinryze - Drug Insights, 2018 US$ 1,000.00

... the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also ...

Jul, 2018 34 pages
Investigation Report on Chinese Rituximab Market, 2018-2022 US$ 2,200.00

... growth potential for the Chinese Rituximab market. Topics Covered: Development environment of Chinese Rituximab market Sales of Rituximab in China Prices of Rituximab in China Progress of generic Rituximab in China Prospects of Chinese Rituximab Market, 2018-2022

Jul, 2018 30 pages
Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022) US$ 1,000.00

... improving healthcare facilities. The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure ...

Jul, 2018 79 pages
Drug Discovery Outsourcing Market Analysis Report By Workflow (Lead Identification & Candidate Optimization, Preclinical Development), By Therapeutic Area, By Drug Type, And Segment... US$ 5,950.00

... drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by Grand View Research, Inc. Urging need to identify potential drug ...

Jun, 2018 175 pages
Investigation Report on Chinese Thymosin α1 Market, 2018-2022 US$ 2,200.00

... China, with its sales value increasing from less than CNY 7 million in 2015 to more than CNY 1.2 billion in 2017. The Chinese Thymosin ... Size of Chinese Thymosin α1 market Competition pattern of the Chinese Thymosin α1 market Prices in the Chinese Thymosin α1 market Prospects of the Chinese Thymosin α1 market

Jul, 2018 30 pages
Investigation Report on Chinese Sorafenib Market, 2018-2022 US$ 2,200.00

... that China-made Sorafenib will appear on the market after 2022. Topics Covered: Sales of Sorafenib in China Prices of Sorafenib in China Sales of Sorafenib in China by region Sales of India-made Sorafenib in China Prospects of Chinese Sorafenib ...

Jul, 2018 30 pages
Investigation Report on Chinese Pregabalin Market, 2018-2022 US$ 2,200.00

... prospect in China. Topics Covered: Development environment of Chinese Pregabalin market Governmental approval of Pregabalin in China Prices of Pregabalin in China Major Pregabalin manufacturers in China Factors influencing the development of Chinese Pregabalin market Prospects of Chinese Pregabalin market

Jul, 2018 30 pages
Investigation Report on Chinese Latanoprost Market, 2018-2022 US$ 2,200.00

... -operative medications, and thus a high demand for Latanoprost in China. Topics Covered: Development environment of Latanoprost in China Sales of Latanoprost in China Major Latanoprost manufacturers in China Retail prices of Latanoprost in China Prospects of Chinese Latanoprost market

Jul, 2018 30 pages
Investigation Report on Chinese Imatinib Market, 2018-2022 US$ 2,200.00

... environment of Imatinib in China Forecast on market size of Imatinib in China Market share of major Imatinib manufacturers in China Retail prices of Imatinib in China Development of generic Imatinib in China India-made Imatinib smuggled to China Prospects of Chinese Imatinib market, 2018 ...

Jul, 2018 30 pages
Investigation Report on Chinese Epoetin Alfa Market, 2018-2022 US$ 2,200.00

... and the increase of residents' income. Topics Covered: Development environment of Epoetin Alfa in China Demand for Epoetin Alfa in China Major Epoetin Alfa Manufacturers in China Prices of Epoetin Alfa in China Prospects of Chinese Epoetin Alfa Market

Jul, 2018 30 pages
Osteoporosis: Global Drug Forecast and Market Analysis to 2027 US$ 10,995.00

Osteoporosis: Global Drug Forecast and Market Analysis to 2027 SUMMARY Osteoporosis is a disease in which the density and quality of bone are reduced ... therapies will shape the osteoporosis market over the forecast period. However, poor diagnosis rates, badly perceived drug side effects, and low ...

Apr, 2018 198 pages
1 2 3 4 5 >
Skip to top